ABOUT · UKMC GROUP LTD · UKMCEVENTS.COM
The senior two-day closed forum for cannabis investors, family offices, private wealth owners, policymakers and global industry leaders. London, June 2027. Organised by UKMC Group Ltd.
THE SUMMIT
The UK Medical Cannabis Investment Summit 2027 is the senior two-day closed forum bringing together the investors, family offices, private wealth owners, fund managers, clinicians, policymakers and global industry leaders defining the future of medical cannabis investment in the United Kingdom.
The Summit exists because the UK medical cannabis market is at an inflection point. The market reached £226 million in 2025 — growing 103% year-on-year. There are now between 90,000 and 94,000 active patients. Over 40 private clinics are operating nationally. Capital is flowing from private equity, venture capital and family offices. And the regulatory environment — shaped by the ACMD review, CQC scrutiny and the international telemedicine debate — is evolving in ways that will directly determine where investment capital flows and where returns are generated.
The most important conversations about the sector's next chapter are not happening online. They are happening in rooms — between principals, clinicians, policymakers and operators who have chosen to be in the same place at the same time for a substantive purpose.
The UK Medical Cannabis Investment Summit 2027 is that room.
Two days. London. June 2027. By application and verification only.
EDUCATIONAL
Market data, regulatory analysis, clinical evidence and investment strategy — delivered by the sector's most informed voices across two days of structured content.
DEAL-ENABLING
Structured one-to-one meetings, closed investor roundtables and curated networking — connecting capital with operators and advisers in a private, verified environment.
VERIFIED
Every delegate is verified before attending. The Summit is designed for principals — not intermediaries — ensuring every conversation in the room is between decision-makers.
THE ORGANISER
UKMC Group Ltd is a United Kingdom-based cannabis intelligence, advisory and media organisation. We unlock the investment and commercial potential of cannabis through primary market data, independent analysis, strategic advisory services and media publishing — providing the institutional-quality research and sector expertise that serious investors and operators require to make informed decisions in one of the world's fastest-growing regulated healthcare industries.
Our work spans the full spectrum of the global cannabis sector — from UK medical cannabis market intelligence and investment advisory to international regulatory analysis, operator strategy, government engagement and media publishing.
We serve an international client base that includes private equity firms, single family offices, private wealth owners, institutional asset managers, listed companies, blue-chip corporations and government organisations across the United Kingdom, Europe, the Gulf and beyond.
INTELLIGENCE
Primary research, market sizing, patient data, supply chain intelligence, regulatory monitoring and investment trend reporting across UK, European and international cannabis markets.
ADVISORY
Commercial strategy, market entry, investment thesis development, regulatory navigation and operational advisory for cannabis operators, investors and government organisations.
INVESTMENT
Dedicated investment research, deal flow intelligence and sector briefings for family offices, private wealth owners, private equity firms and institutional allocators.
MEDIA & EVENTS
Publisher of Healthcare Investor Magazine — independent investment intelligence for 20,000+ investors and family offices — and organiser of the UK Medical Cannabis Investment Summit.
WHY THIS SUMMIT EXISTS
The global medical cannabis market reached over £2 billion in combined market value across the UK, Germany and Australia in 2025. The UK market alone grew 103% year-on-year — reaching £226 million with 90,000 to 94,000 active patients. Canada exported 275,343 kilograms of medical cannabis in 2025 — more than 2.5 times the prior year. Regulatory frameworks are evolving rapidly across every major market.
Yet despite this growth, the UK medical cannabis investment landscape remains poorly served by the events and forums currently available. General cannabis conferences cover the sector broadly but without the depth, selectivity or investment focus that serious capital allocators require. General investment conferences cover healthcare broadly but without the sector-specific intelligence that medical cannabis demands.
The UK Medical Cannabis Investment Summit 2027 exists to fill that gap — providing a senior, closed, investment-focused forum that meets the standards of the family offices, institutional investors and private wealth owners who are the most important source of patient capital for the UK medical cannabis sector.
UK medical cannabis market size 2025. Source: Prohibition Partners 2026.
UK year-on-year market growth 2025. Source: Prohibition Partners 2026.
Active UK patients 2025. Source: Prohibition Partners 2026.
Canadian medical cannabis exports 2025. Source: Statistics Canada, Prohibition Partners 2026.
Source: Prohibition Partners Global Medical Cannabis Market Review 2026. Data sourced from Statistics Canada, Health Canada, UK Home Office and national regulatory bodies.
WHO ATTENDS
Every delegate at the UK Medical Cannabis Investment Summit 2027 is verified before attending. The Summit is designed for principals — not intermediaries.
Attendance is by application and verification only. Places are strictly limited to preserve the seniority and quality of the room.
THE UKMC GROUP LTD PORTFOLIO
The UK Medical Cannabis Investment Summit is one of four active operations within UKMC Group Ltd — each serving a distinct role in the UK cannabis and healthcare investment ecosystem.
The events and summit division of UKMC Group Ltd — convening senior investors, family offices, clinicians, policymakers and industry leaders across UK healthcare and medical cannabis. The UK Medical Cannabis Investment Summit 2027 is the flagship event of the UKMC Events division.
ukmcevents.comPublished by UKMC Media, Healthcare Investor Magazine is an independent investment intelligence publication for investors, family offices, private wealth owners and industry professionals active across UK healthcare, life sciences and medical cannabis. 20,000+ opted-in subscribers. Free and premium subscription tiers available.
healthcareinvestormagazine.comUKMC Lounges operates professional, compliant membership spaces for verified UK medical cannabis patients. The flagship UKMC Lounge Norwich opens in Q1 2027 — providing a discreet, hygienic and professionally managed environment for adults holding valid UK medical cannabis prescriptions.
ukmclounges.comUKMC Group Ltd's advisory and intelligence division — providing primary market data, investment research, regulatory analysis, strategic advisory and deal flow intelligence to investors, operators, blue-chip corporations and government organisations across the UK and internationally.
info@ukmcgroup.co.ukGET IN TOUCH
For registration, attendance and ticket enquiries about the UK Medical Cannabis Investment Summit 2027.
For sponsorship, partnership and commercial enquiries about the Summit and UKMC Group Ltd.
For general enquiries, intelligence and advisory services, media and Healthcare Investor Magazine.